Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Uterine Cervical Dysplasia × poly(gamma-glutamic acid) × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Dysplasia 1

Interventions

Papillomavirus Vaccines 2 Imiquimod 2 GX-188 vaccine 2 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2 poly(gamma-glutamic acid) 1 pembrolizumab 1 nimotuzumab 1 artesunic acid 1 artemisinin 1 Sutures 1 Progesterone 1 Omeprazole 1 Ointments 1 Ocoxin 1 Nelfinavir 1 Indomethacin 1 IRX 2 1 Hepatitis B Vaccines 1 Geritol 1 GPI0100 1 Folic Acid 1 Eflornithine 1 Cyclophosphamide 1 Conization 1 Cisplatin 1 Chemoprevention 1 Celecoxib 1 Brachytherapy 1 Biological Therapy 1 Antigens 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01826045 2016-01-29

PGA

BioLeaders Corporation

Phase 2 Completed

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡